- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
medmix AG (MEDX)
medmix AG stock price live, this page displays SIX MEDX stock exchange data. View the MEDX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the medmix AG real time stock price chart below.
What Is the medmix AG Stock Price Today?
The medmix AG stock price today is 8.96.
What Is the Stock Symbol for medmix AG?
The stock symbol for medmix AG is "MEDX."
What Stock Exchange Does medmix AG Trade On?
medmix AG is listed and trades on the Switzerland stock exchange.
Is medmix AG a Good Stock to Buy?
Determining whether medmix AG—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MEDX quote. (ISIN: CH1129677105)
What Is the medmix AG Stock Price Today?
The medmix AG stock price today is 8.96.
What Is the Stock Symbol for medmix AG?
The stock symbol for medmix AG is "MEDX."
What Stock Exchange Does medmix AG Trade On?
medmix AG is listed and trades on the Switzerland stock exchange.
Is medmix AG a Good Stock to Buy?
Determining whether medmix AG—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MEDX quote. (ISIN: CH1129677105)
Switzerland
Currency in CHF
8.96
-0.26(-2.82%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.85
9.15
52 wk Range
8.18
13.02
High dividend Yield
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.859.15
52 wk Range
8.1813.02
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(5.58%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(5.58%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
MEDX Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
16.63
Upside
+85.64%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
- medmix receives Investment Bank Analyst Rating Update
- Investing.com
Pro - medmix AG receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- medmix receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
medmix AG designs, produces, and sells high-precision devices and services in Switzerland and internationally. It operates through the Healthcare, and Consumer and Industrial segments. The company offers dispensers, cartridges, mixers, tips, syringes, pen, and auto injectors for delivery of dental materials; delivery devices and mixing for bone repair and tissue treatment, which are used for prosthetics, restoratives, anesthetics, and aesthetics; the pen and auto injectors, which are used in fertility and growth hormone treatments, treatment of diabetes, osteoporosis, and other diseases; and the delivery and mixing devices, which are used by tissue banks and medical device OEMs. It also produces and markets dispensers, cartridges, and mixers for two-component adhesives and sealants for use in construction, transportation, electronics, infrastructure, and general industrial sectors; and micro-brushes and applicators for eyes, eyelashes, lips, and facial make-up. The company offers its products under the Mixpac, Transcodent, Qiaoyi, Cox, MK, Medmix, Haselmeier, and Geka brands. medmix AG was founded in 1922 and is based in Baar, Switzerland.
medmix AG Earnings Call Summary for H2/2025
- Medmix revenue fell 7.4% to CHF 448M in 2025, pressured by FX headwinds and organic decline; stock dropped 19% post-earnings.
- Adjusted EBITDA margin reached 20%, exceeding expectations; gross profit margin expanded to 36.1% from 33.0% year-over-year.
- EBIT surged 76.7% to CHF 22.8M; Growth and Efficiency program successfully drove profitability despite revenue challenges.
- Healthcare segment increased contribution to 38% of revenue, while Consumer and Industrial segments declined amid market headwinds.
- CEO emphasized focus on margin enhancement and balance sheet strength; FX volatility and segment declines remain key risks ahead.
Last Updated: 2026-02-26, 05:40 a/m
Read Full TranscriptCompare MEDX to Peers and Sector
Metrics to compare | MEDX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMEDXPeersSector | |
|---|---|---|---|---|
P/E Ratio | 58.6x | 15.3x | −0.5x | |
PEG Ratio | 0.32 | 0.01 | 0.00 | |
Price/Book | 0.9x | 1.7x | 2.6x | |
Price / LTM Sales | 0.8x | 1.8x | 3.2x | |
Upside (Analyst Target) | 73.5% | 26.7% | 51.2% | |
Fair Value Upside | Unlock | 6.2% | 7.3% | Unlock |
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 16.63
(+85.64% Upside)
Earnings
Latest Release
Feb 26, 2026
EPS / Forecast
-0.01 / --
Revenue / Forecast
222.60M / --
People Also Watch
FAQ
What Is the medmix (MEDX) Stock Price Today?
The medmix stock price today is 8.96 CHF.
What Stock Exchange Does medmix Trade On?
medmix is listed and trades on the Switzerland Stock Exchange.
What Is the Stock Symbol for medmix?
The stock symbol for medmix is "MEDX."
Does medmix Pay Dividends? What’s The Current Dividend Yield?
The medmix dividend yield is 5.58%.
What Is the medmix Market Cap?
As of today, medmix market cap is 364.43M CHF.
What Is medmix's Earnings Per Share (TTM)?
The medmix EPS (TTM) is 0.16.
From a Technical Analysis Perspective, Is MEDX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has medmix Stock Split?
medmix has split 0 times.
How Many Employees Does medmix Have?
medmix has 2667 employees.
What is the current trading status of medmix (MEDX)?
As of Mar 10, 2026, medmix (MEDX) is trading at a price of 8.96 CHF, with a previous close of 9.22 CHF. The stock has fluctuated within a day range of 8.85 CHF to 9.15 CHF, while its 52-week range spans from 8.18 CHF to 13.02 CHF.
What Is medmix (MEDX) Price Target According to Analysts?
The average 12-month price target for medmix is 16.63 CHF, with a high estimate of 18 CHF and a low estimate of 15.9 CHF. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +85.64% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.